📉 DNOW leads Day Losers — median loss ~11%, 19 of 25 in lower 40% of ranges; tech, health, finance under pressure | February 23, 2026
Spotlight on DNOW, NVO, CRWD and more. The data suggests a bearish, high‑risk Day Losers universe with widespread deep declines and elevated volume spikes—indicative of strong selling and selective capitislation. A small subset of large volume, near‑low names (DNOW, NVO, BL) look like tactical bounce candidates if price/volume confirmation occurs; many growth/unprofitable names remain volatile and warrant caution. Trade signals should rely on multi‑session confirmation and strict risk management rather than single‑day bounces.
Top Picks
Disclaimer: This AI-generated analysis is for educational and informational purposes only. It does not constitute financial advice. Always do your own research and consult with a licensed financial advisor before making investment decisions.
Market Overview
Key Observation
The data suggests broad downside pressure across the Day Losers list with a median loss of ~11% and 19 of 25 names sitting in the lower 40% of their 52‑week ranges, indicating widespread deep declines. Several names show unusually high intraday volume spikes while remaining in downtrends, signaling capitulation or forced selling.
Volume Analysis
The data suggests elevated volume overall (median volume spike 2.2x) with pronounced outliers (DNOW 6.28x, CRWD 5.31x, STEP 5.16x, NVO 4.44x, BL 3.31x). This concentration of volume on big decliners points to high conviction flows (liquidation or block selling) and selective interest in potential bounce/reversal setups.
Top PicksShowing 2 of 5
DNOW
Analysis
The data suggests DNOW is a high-probability bounce candidate: very large volume spike (6.28x vs 3‑month average) coincides with a price sitting near the low end of its 52‑week range (range_position 1.9) and an analyst consensus of Strong Buy. Its valuation metrics (PE 13.6, PB 1.0) are not stretched relative to many losers here, so buyers could step in on a volume-confirmed reversal. Momentum score is low (30) and trend listed as Downtrend, so any entry should wait for clear price/volume confirmation.
Key Metrics
volume_ratio 6.28x; range_position 1.9; analyst_rating Strong Buy
Risk Factors
Downtrend/momentum weak; heavy intraday selling may continue.
Suggested Action
The data suggests monitoring for a continued intraday/next‑day close with sustained volume >2x and a clear reversal candle; consider scaling exposure only after volume confirmation and using a tight stop near recent intraday lows.
NVO
Analysis
The data suggests Novo Nordisk is an oversold large‑cap that is trading effectively at its 52‑week low (range_position 0.5) on an elevated volume spike (4.44x) and carries a meaningful dividend (3.92%). Its sizeable market cap ($176B) and standard valuation profile (PE 10.8) indicate potential buyer interest if selling pressure eases. However momentum score is low (15) and the listed trend is Downtrend, so the stock requires confirmation of stabilization before expecting a durable rebound.
Key Metrics
range_position 0.5; volume_ratio 4.44x; dividend_yield 3.92%
Risk Factors
Large-cap downtrend may persist; momentum is weak.
Suggested Action
The data suggests watching for consolidation with continued above-average volume or a multi-session base; consider a measured engagement after a confirmed reversal and use a defined stop below the consolidation low.
+3 more top picks available
Sign up free to unlock all picks
Unlock Full Analysis
Sign up for free to access the complete Day Losers Analysis analysis
You're missing out on:
By signing up, you agree to our Terms of Service and Privacy Policy